Prognostic value of microRNA expression pattern in upper tract urothelial carcinoma

dc.contributor.authorIzquierdo Reyes, Laura
dc.contributor.authorIngelmo-Torres, Mercedes
dc.contributor.authorMallofré i Gómez, Carme
dc.contributor.authorLozano Salvatella, Juan José
dc.contributor.authorVerhasselt-Crinquette, Marie
dc.contributor.authorLeRoy, Xavier
dc.contributor.authorColin, Pierre
dc.contributor.authorComperat, Eva
dc.contributor.authorRoupret, Morgan
dc.contributor.authorAlcaraz Asensio, Antonio
dc.contributor.authorMengual Brichs, Lourdes
dc.date.accessioned2015-01-09T13:40:19Z
dc.date.available2015-04-09T22:01:34Z
dc.date.issued2014-04-09
dc.date.updated2015-01-09T13:40:19Z
dc.description.abstractOBJECTIVE: To examine the microRNA (miRNA) expression pattern in tumour samples from patients with progressing and non-progressing upper tract urothelial carcinoma (UTUC) in order to identify putative miRNAs that may be used as prognostic markers. PATIENTS AND METHODS: We conducted a multicentre, retrospective study of formalin-fixed paraffin-embedded tissue samples from 150 patients with UTUC who had undergone radical nephroureterectomy. Global miRNA expression patterns were analysed in 18 selected samples from patients with UTUC using TaqMan arrays. The differential expression of five key miRNAs was validated by quantitative polymerase chain reaction in an independent cohort of 132 samples from patients with UTUC. Models to predict tumour progression and cancer-specific survival that included miRNA expression patterns were developed by Cox regression analysis. RESULTS: Twenty-six miRNAs were found to be aberrantly expressed between samples from patients with progressing and non-progressing UTUC and five of these were selected for subsequent studies. The regression analysis identified tumour stage and miR-31 and miR-149 expression as independently associated with tumour progression and tumour stage and miR-149 expression as independently associated with cancer-specific survival. The risk scores derived from these miRNA models were able to discriminate two groups with a highly significantly different probability of tumour progression (hazard ratio [HR] 4.78; P < 0.001) and death (HR 276; P = 0.004). CONCLUSIONS: There is a differential miRNA expression pattern between patients with progressing and non-progressing UTUC. The identification of new miRNAs associated with a high probability of tumour recurrence and cancer-specific survival in patients with UTUC and their combination in a robust, easy-to-use and reliable algorithm may help tailor treatment and surveillance strategies in these patients.
dc.format.extent28 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec637785
dc.identifier.issn1464-4096
dc.identifier.pmid24180461
dc.identifier.urihttps://hdl.handle.net/2445/61131
dc.language.isoeng
dc.publisherWiley
dc.relation.isformatofVersió postprint del document publicat a: http://dx.doi.org/10.1111/bju.12551
dc.relation.ispartofBJU International, 2014, vol. 113, num. 5, p. 813-821
dc.relation.urihttp://dx.doi.org/10.1111/bju.12551
dc.rights(c) BJU International, 2014
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Ciències Fisiològiques)
dc.subject.classificationMalalties de l'aparell urinari
dc.subject.classificationCàncer
dc.subject.classificationMicro RNAs
dc.subject.classificationReacció en cadena de la polimerasa
dc.subject.otherDiseases of the urinary organs
dc.subject.otherCancer
dc.subject.otherMicroRNAs
dc.subject.otherPolymerase chain reaction
dc.titlePrognostic value of microRNA expression pattern in upper tract urothelial carcinoma
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/acceptedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
637785.pdf
Mida:
857.51 KB
Format:
Adobe Portable Document Format